LLIT vs. INFU, NSPR, CTCX, HSAQ, TMDIF, GBS, RVP, PETV, NURO, and BTCY
Should you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include InfuSystem (INFU), InspireMD (NSPR), Carmell (CTCX), Health Sciences Acquisitions Co. 2 (HSAQ), Titan Medical (TMDIF), GBS (GBS), Retractable Technologies (RVP), PetVivo (PETV), NeuroMetrix (NURO), and Biotricity (BTCY). These companies are all part of the "medical" sector.
Lianluo Smart vs. Its Competitors
InfuSystem (NYSE:INFU) and Lianluo Smart (NASDAQ:LLIT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk.
InfuSystem has a beta of 1.81, suggesting that its share price is 81% more volatile than the S&P 500. Comparatively, Lianluo Smart has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500.
In the previous week, InfuSystem's average media sentiment score of 0.00 equaled Lianluo Smart'saverage media sentiment score.
71.1% of InfuSystem shares are held by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are held by institutional investors. 11.4% of InfuSystem shares are held by company insiders. Comparatively, 22.9% of Lianluo Smart shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
InfuSystem has higher revenue and earnings than Lianluo Smart.
InfuSystem has a net margin of 1.12% compared to Lianluo Smart's net margin of 0.00%. InfuSystem's return on equity of 2.78% beat Lianluo Smart's return on equity.
InfuSystem currently has a consensus target price of $13.00, suggesting a potential upside of 106.68%. Given InfuSystem's stronger consensus rating and higher possible upside, research analysts clearly believe InfuSystem is more favorable than Lianluo Smart.
Summary
InfuSystem beats Lianluo Smart on 10 of the 12 factors compared between the two stocks.
Get Lianluo Smart News Delivered to You Automatically
Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Lianluo Smart Competitors List
Related Companies and Tools
This page (NASDAQ:LLIT) was last updated on 7/9/2025 by MarketBeat.com Staff
